| Bioactivity | Batifiban, a cyclic peptide, is a platelet glycoprotein GPⅡb/Ⅲa antagonist, and inhibits platelet aggregation. Batifiban blocks circulating vitronectin binding to integrin ανβ3, Batifiban can be used for research of acute coronary syndromes[1]. |
| Name | Batifiban |
| CAS | 710312-77-9 |
| Sequence | {Mpa}-Cys-Arg-Gly-Asp-Trp-Pro-Cys-NH2 (Disulfide bridge：Mpa1-Cys7) |
| Shortening | {Mpa}-RGDWPC-NH2 (Disulfide bridge: Mpa1-Cys7) |
| Formula | C34H47N11O9S2 |
| Molar Mass | 817.94 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Chen H, et al. Safety, pharmacokinetic and pharmacodynamic studies of batifiban injection following single- and multiple-dose administration to healthy Chinese subjects. J Huazhong Univ Sci Technolog Med Sci. 2009 Feb;29(1):12-8. |
Batifiban
CAS: 710312-77-9 F: C34H47N11O9S2 W: 817.94
Batifiban, a cyclic peptide, is a platelet glycoprotein GPⅡb/Ⅲa antagonist, and inhibits platelet aggregation. Batifib
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.